Share

October 29, 2013; 81 (18) Editorial

Is α-synuclein rising to the surface as a diagnostic biomarker for Parkinson disease?

William P. Cheshire, Ronald F. Pfeiffer
First published October 2, 2013, DOI: https://doi.org/10.1212/WNL.0b013e3182a9f5ab
Full PDF
Citation
Permissions

Make Comment

See Comments

Downloads
262

Share

Article Information

vol. 81 no. 18 1568-1569
DOI: 
https://doi.org/10.1212/WNL.0b013e3182a9f5ab
PubMed: 
24089391
Published By: 
Wolters Kluwer Health, Inc. on behalf of the American Academy of Neurology
Print ISSN: 
0028-3878
Online ISSN: 
1526-632X
History: 
  • First Published October 2, 2013.

Article Versions

Copyright & Usage: 
© 2013 American Academy of Neurology

Author Disclosures

    1. William P. Cheshire, MD and
    2. Ronald F. Pfeiffer, MD
  1. William P. Cheshire, MD and
    2. Scientific Advisory Boards:

    1. NONE

    Gifts:

    1. NONE

    Funding for Travel or Speaker Honoraria:

    1. NONE

    Editorial Boards:

    1. NONE

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. American Academy of Neurology, Neuro SAE examination writer, 2013

    Speakers' Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. NONE

    Research Support, Government Entities:

    1. National Institutes of Health, Autonomic Rare Diseases Clinical Research Consortium, 6102, Principal Investigator, 2011-2013

    Research Support, Academic Entities:

    1. Mayo Clinic Program in Professionalism & Ethics, PPE-5 grant, Principal Investigator, 2013-2014

    Research Support, Foundations and Societies:

    1. NONE

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  2. Ronald F. Pfeiffer, MD
    3. Scientific Advisory Boards:

    1. (1) National Parkinson Foundation

    Gifts:

    1. NONE

    Funding for travel or speaker honoraria:

    1. (1)Teva (2)UCB (3)USWorldMeds

    Editorial Boards:

    1. (1) Parkinsonism and Related Disorders, Co-Editor in Chief 2008-present (2) Journal of Parkinson's Disease, Editorial Board Member, 2011-present (3) International Journal of Brain Science, Editorial Board Member, 2013-present

    Patents:

    1. NONE

    Publishing Royalties:

    1. (1) Parkinson's Disease, Second Edition, Taylor & Francis, 2013 (2) Parkinson's Disease and Nonmotor Dysfunction, Second Edition, Humana Press, 2013

    Employment, Commercial Entity:

    1. (1) University of Tennessee Health Science Center (2) Semmes-Murphey Neurologic & Spine Institute

    Consultancies:

    1. (1) UCB

    Speakers' Bureaus:

    1. (1)Teva (2)UCB (3)USWorldMeds

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. (1) Boehringer-Ingelheim (2) UCB (3) Phytopharm

    Research Support, Government Entities:

    1. NONE

    Research Support, Academic Entities:

    1. (1) Columbia University (CORE-PD Study) (2) Weill Cornell Medical College (QE3 Study) (3) Northwestern University (STEADY-PD Study) (4) Indiana University (PROGENI Study)

    Research Support, Foundations and Societies:

    1. (1) Parkinson Study Group (2) Michael J Fox Foundation - (I did not receive funding directly from MJFF, but they provided funding for the STEADY-PD Study listed above)

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. (1) Tucker Ellis & West, consultant (2) Thomas, Thomas and Hafer, consultant

  1. From the Department of Neurology (W.P.C.), Mayo Clinic, Jacksonville, FL; and Department of Neurology (R.F.P.), University of Tennessee Health Science Center, Memphis.
  1. Correspondence to Dr. Cheshire: cheshire{at}mayo.edu
View Full Text

Article usage

Article usage: October 2013 to February 2023

AbstractFullPdfSource
Oct 201356440139Highwire
Nov 20131805143Highwire
Dec 201335148Highwire
Jan 2014422321Highwire
Feb 2014835Highwire
Mar 20142634Highwire
Apr 20141346Highwire
May 20141321Highwire
Jun 20141802Highwire
Jul 20141723Highwire
Aug 2014133Highwire
Sep 20141010Highwire
Oct 2014713Highwire
Nov 2014211Highwire
Dec 20141110Highwire
Jan 2015801Highwire
Feb 2015414Highwire
Mar 20151011Highwire
Apr 2015510Highwire
May 2015641Highwire
Jun 2015800Highwire
Jul 20151700Highwire
Aug 20151002Highwire
Sep 20151110Highwire
Oct 2015800Highwire
Nov 2015800Highwire
Dec 20151110Highwire
Jan 2016500Highwire
Feb 2016800Highwire
Mar 2016300Highwire
Apr 2016411Highwire
May 2016400Highwire
Jun 2016600Highwire
Jul 20161300Highwire
Aug 20161301Highwire
Sep 2016400Highwire
Oct 2016900Highwire
Nov 20161500Highwire
Dec 2016600Highwire
Jan 20171000Highwire
Feb 20171022Highwire
Mar 2017600Highwire
Apr 2017500Highwire
May 2017600Highwire
Jun 2017100Highwire
Jul 2017200Highwire
Aug 2017400Highwire
Sep 2017300Highwire
Oct 2017100Highwire
Nov 2017200Highwire
Dec 2017100Highwire
Jan 2018600Highwire
Feb 2018701Highwire
Mar 2018800Highwire
Apr 2018300Highwire
May 20183100Highwire
Jun 20181100Highwire
Jul 2018100Highwire
Aug 2018200Highwire
Sep 20181600Highwire
Oct 2018500Highwire
Nov 2018100Highwire
Dec 2018600Highwire
Jan 2019400Highwire
Feb 20191610Highwire
Mar 2019700Highwire
Apr 20192100Highwire
May 2019100Highwire
Jun 2019300Highwire
Jul 2019200Highwire
Aug 2019200Highwire
Oct 20191200Highwire
Nov 20191100Highwire
Dec 2019501Highwire
Jan 2020500Highwire
Feb 2020800Highwire
Mar 2020400Highwire
Apr 2020311Highwire
May 2020201Highwire
Jun 20201100Highwire
Jul 2020500Highwire
Aug 2020500Highwire
Sep 2020300Highwire
Oct 2020222Highwire
Nov 20201420Highwire
Dec 2020400Highwire
Jan 2021900Highwire
Feb 20211730Highwire
Mar 2021900Highwire
Apr 20211120Highwire
May 2021900Highwire
Jun 20211050Highwire
Jul 20211520Highwire
Aug 20211111Highwire
Sep 2021800Highwire
Oct 2021800Highwire
Nov 20212000Highwire
Dec 20211211Highwire
Jan 2022600Highwire
Feb 20221300Highwire
Mar 20221300Highwire
Apr 2022400Highwire
May 2022900Highwire
Jun 2022600Highwire
Jul 2022401Highwire
Aug 20221100Highwire
Sep 2022511Highwire
Oct 2022700Highwire
Nov 2022610Highwire
Dec 2022210Highwire
Jan 2023500Highwire
Feb 2023600Highwire

Letters: Rapid online correspondence

No comments have been published for this article.
Comment

REQUIREMENTS

If you are uploading a letter concerning an article:
You must have updated your disclosures within six months: http://submit.neurology.org

Your co-authors must send a completed Publishing Agreement Form to Neurology Staff (not necessary for the lead/corresponding author as the form below will suffice) before you upload your comment.

If you are responding to a comment that was written about an article you originally authored:
You (and co-authors) do not need to fill out forms or check disclosures as author forms are still valid
and apply to letter.

Submission specifications:

  • Submissions must be < 200 words with < 5 references. Reference 1 must be the article on which you are commenting.
  • Submissions should not have more than 5 authors. (Exception: original author replies can include all original authors of the article)
  • Submit only on articles published within 6 months of issue date.
  • Do not be redundant. Read any comments already posted on the article prior to submission.
  • Submitted comments are subject to editing and editor review prior to posting.

More guidelines and information on Disputes & Debates

Compose Comment

More information about text formats

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.
Author Information
NOTE: The first author must also be the corresponding author of the comment.
First or given name, e.g. 'Peter'.
Your last, or family, name, e.g. 'MacMoody'.
Your email address, e.g. higgs-boson@gmail.com
Your role and/or occupation, e.g. 'Orthopedic Surgeon'.
Your organization or institution (if applicable), e.g. 'Royal Free Hospital'.
Publishing Agreement
NOTE: All authors, besides the first/corresponding author, must complete a separate Publishing Agreement Form and provide via email to the editorial office before comments can be posted.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

Vertical Tabs

You May Also be Interested in

Back to top
Advertisement

Related Articles

Topics Discussed

Alert Me

Recommended articles